<?xml version="1.0" encoding="UTF-8"?>
<ref id="B44-nanomaterials-10-01072">
 <label>44.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Freeling</surname>
    <given-names>J.P.</given-names>
   </name>
   <name>
    <surname>Koehn</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Shu</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Ho</surname>
    <given-names>R.J.Y.</given-names>
   </name>
  </person-group>
  <article-title>Anti-HIV drug-combination nanoparticles enhance plasma drug exposure duration as well as triple-drug combination levels in cells within lymph nodes and blood in primates</article-title>
  <source>AIDS Res. Hum. Retrovir.</source>
  <year>2015</year>
  <volume>31</volume>
  <fpage>107</fpage>
  <lpage>114</lpage>
  <pub-id pub-id-type="doi">10.1089/aid.2014.0210</pub-id>
  <?supplied-pmid 25402233?>
  <pub-id pub-id-type="pmid">25402233</pub-id>
 </element-citation>
</ref>
